Mod GRF 1-29 (CJC-1295 NO DAC) (5mg)
$46.00
Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) is offered by Biotech Peptides for laboratory and analytical research. Mod GRF 1-29 is a synthetic 29-residue GHRH analogue studied in relation to growth hormone-releasing hormone receptor signaling and somatotroph cell function. 1056
-
Product: Mod GRF 1-29
-
Alternative name: CJC-1295 without DAC
-
Listed quantity: 5 mg
-
Reference molecular formula: C₁₅₂H₂₅₂N₄₄O₄₂
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) for Laboratory Research
Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) is offered by Biotech Peptides for laboratories investigating growth hormone-releasing hormone receptor signaling, somatotroph cell function, and growth hormone pulsatility dynamics. Mod GRF 1-29 is a synthetic 29-residue GHRH analogue with four stabilizing substitutions relative to native GHRH(1-29). 1056
For laboratories looking to buy Mod GRF 1-29, this listing identifies a 5 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
Mod GRF 1-29 Product Information
| Property | Listing information |
|---|---|
| Product name | Mod GRF 1-29 |
| Alternative name | CJC-1295 without DAC |
| Listed quantity | 5 mg |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 5 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.
Mod GRF 1-29 Reference Molecular Characteristics
The following characteristics describe the Mod GRF 1-29 reference structure. They are not analytical confirmation of an individual commercial batch.
| Reference characteristic | Information |
|---|---|
| Peptide length | 29 residues |
| Reference sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Molecular formula | C₁₅₂H₂₅₂N₄₄O₄₂ |
| Approximate molecular weight | 3367.9 g/mol |
| CAS number | 863288-34-0 |
| Chemical class | Synthetic GHRH analogue |
The sequence, molecular formula, molecular weight, and CAS number are documented in the Mod GRF 1-29 research summary and in the Mod GRF 1-29 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1056
Mod GRF 1-29 and GHRH Receptor Research
Mod GRF 1-29 binds selectively to the GHRH receptor, a class B G-protein-coupled receptor expressed predominantly on somatotroph cells in the anterior pituitary. Receptor engagement activates adenylyl cyclase, increasing intracellular cyclic AMP concentrations. 1060
A review of GHRH receptor signaling describes GHRH-R as the most important GPCR in regulating GH release. The same review notes that GHRH-R is reportedly stimulated by LPS. 1054
Read the review of GHRH receptor signaling for the molecular mechanisms and evidence limitations.
Growth Hormone Pulsatility Research
A study evaluating a Modified GRF 1-29 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. The same study reported an approximately 28% increase in IGF-1 levels. 1060
A separate study of CJC-1295, a long-acting GHRH analog, reported that the peptide promoted an increase in GH and IGF-1 levels in sera of healthy young adult men one week after administration.
These findings apply to specific experimental protocols and do not establish that a commercial Mod GRF 1-29 batch increases growth hormone in humans. 1060
Research Limitations
Published Mod GRF 1-29 research examines receptor signaling, cell-based assays, and animal models. It does not establish that Mod GRF 1-29 increases growth hormone, improves body composition, supports recovery, or treats any condition. 1054
Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.
Documentation and Batch Verification
Before selecting Mod GRF 1-29 (CJC-1295 NO DAC) (5mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.
For inquiries, provide “Mod GRF 1-29 (CJC-1295 NO DAC) (5mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About Mod GRF 1-29 (CJC-1295 NO DAC) (5mg)
What is Mod GRF 1-29?
Mod GRF 1-29 is a synthetic 29-residue GHRH analogue with four stabilizing substitutions relative to native GHRH(1-29). 1056
Is Mod GRF 1-29 the same as CJC-1295?
No. Mod GRF 1-29 is structurally identical to CJC-1295 without DAC. It is not the same molecule as CJC-1295 with DAC. 1057
Does Mod GRF 1-29 increase growth hormone?
A study evaluating a Modified GRF 1-29 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. This does not establish that a commercial Mod GRF 1-29 batch increases growth hormone in humans. 1060
What does the 5mg designation mean?
It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
Mod GRF 1-29 (CJC-1295 NO DAC) (5mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
ACE-031 (1mg)
ACE-031 (1mg) is offered by Biotech Peptides for laboratory and analytical research. ACE-031 is a soluble fusion protein comprising the extracellular domain of activin receptor type IIB fused to the Fc portion of human IgG1, studied in relation to myostatin signaling and muscle-mass regulation. 1198
-
Product: ACE-031
-
Alternative name: Ramatercept
-
Listed quantity: 1 mg
-
Reference molecular weight: 77.24 kDa
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Lipopeptide (Biopeptide EL) (200mg)
- Product name: Lipopeptide (Biopeptide EL)
- Listed quantity: 200mg
- Chemical name: Palmitoyl Hexapeptide-12
- Peptide sequence: Val-Gly-Val-Ala-Pro-Gly (VGVAPG)
- Molecular formula: C₃₈H₆₈N₆O₈
- Molecular weight: Approximately 737.0 g/mol
- CAS number: 171263-26-6
Nonapeptide-1 (200mg)
- Product: Nonapeptide-1
- Alternative name: Melanostatine-5
- Listed quantity: 200mg
- Peptide length: 9 amino acids
- Reference sequence: Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH₂
- CAS number: 158563-45-2
Pal-AHK (200mg) | Biotech Peptides
Pal-AHK (200mg) is listed as a palmitoylated AHK tripeptide for laboratory and analytical research. The supplied product description identifies the proposed structure as palmitoyl-Ala-His-Lys, combining an alanine-histidine-lysine peptide sequence with an N-terminal palmitoyl group.
Proposed reference characteristics (subject to manufacturer confirmation):- Listed quantity: 200mg
- Proposed peptide sequence: Ala-His-Lys (AHK)
- Proposed modification: N-terminal palmitoyl group
- Proposed molecular formula: C₃₁H₅₆N₆O₅
- Proposed molecular weight: Approximately 592.8 g/mol
Pentapeptide-18 (Leuphasyl) (200mg) | Biotech Peptides
Pentapeptide-18 (Leuphasyl) (200mg) is a synthetic pentapeptide listed for laboratory and analytical research involving peptide structure and cosmetic-science research models.
Pentapeptide-18 is also known as Leuphasyl and is structurally related to leucine-enkephalin, with a D-alanine residue at position two. Its research background includes investigations into neurotransmitter signaling and topical cosmetic formulations. Reference molecular information:- Listed quantity: 200mg
- Sequence: H-Tyr-D-Ala-Gly-Phe-Leu-OH
- Molecular formula: C₂₉H₃₉N₅O₇
- Molecular weight: Approximately 569.6 g/mol
- CAS number: 64963-01-5
- Alternative name: Leuphasyl
TB-500 (Thymosin Beta-4) (5mg)
TB-500 (Thymosin Beta-4) (5mg) is offered by Biotech Peptides for laboratory and analytical research. TB-500 is a synthetic 43-residue peptide derived from thymosin beta-4, studied in relation to cell migration, angiogenesis, and wound-repair signaling. 1110
-
Product: TB-500
-
Full name: Thymosin Beta-4
-
Listed quantity: 5 mg
-
Reference molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Tesamorelin (5mg & 10mg)
Tesamorelin (5mg & 10mg) is offered by Biotech Peptides for laboratory and analytical research. Tesamorelin is a synthetic 44-residue GHRH analogue studied in relation to growth hormone secretion, visceral adiposity, and metabolic signaling. 1137
-
Product: Tesamorelin
-
Full name: N-(trans-3-hexenoyl)-[Tyr1]-hGRF(1-44)-NH2 acetate
-
Listed quantities: 5 mg and 10 mg
-
Reference molecular formula: C₂₂₁H₃₆₆N₇₂O₆₇S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
